These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 16632399)
1. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities]. Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399 [TBL] [Abstract][Full Text] [Related]
2. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788 [TBL] [Abstract][Full Text] [Related]
3. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336 [TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040 [TBL] [Abstract][Full Text] [Related]
5. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. Rouëssé J; de la Lande B; Bertheault-Cvitkovic F; Serin D; Graïc Y; Combe M; Leduc B; Lucas V; Demange L; Nguyen TD; Castèra D; Krzisch C; Villet R; Mouret-Fourme E; Garbay JR; Noguès C; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1072-80. PubMed ID: 16504757 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of concurrent adjuvant chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer. Han S; Kim J; Sohn S; Kwak GH; Kim JY; Park K J Surg Oncol; 2007 Jan; 95(1):45-50. PubMed ID: 17192866 [TBL] [Abstract][Full Text] [Related]
7. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Johansen J; Overgaard J; Overgaard M Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320 [TBL] [Abstract][Full Text] [Related]
8. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views. Toledano AH; Bollet MA; Fourquet A; Azria D; Gligorov J; Garaud P; Serin D; Bosset JF; Miny-Buffet J; Favre A; LeFoch O; Calais G Int J Radiat Oncol Biol Phys; 2007 May; 68(1):66-72. PubMed ID: 17448869 [TBL] [Abstract][Full Text] [Related]
9. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711 [TBL] [Abstract][Full Text] [Related]
10. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases. Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442 [TBL] [Abstract][Full Text] [Related]
11. Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment. Ellerbroek N; Martino S; Mautner B; Tao ML; Rose C; Botnick L Breast J; 2003; 9(2):74-8. PubMed ID: 12603378 [TBL] [Abstract][Full Text] [Related]
12. Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer. Pernin V; Belin L; Cottu P; Bontemps P; Lemanski C; De La Lande B; Baumann P; Missohou F; Levy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Bollet M; Vago NA; Dendale R; Campana F; Fourquet A; Kirova YM Br J Radiol; 2015 Apr; 88(1048):20140800. PubMed ID: 25645108 [TBL] [Abstract][Full Text] [Related]
13. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F Breast J; 2011; 17(6):586-93. PubMed ID: 21951485 [TBL] [Abstract][Full Text] [Related]
14. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes. Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965 [TBL] [Abstract][Full Text] [Related]
15. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J; J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969 [TBL] [Abstract][Full Text] [Related]
16. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333 [TBL] [Abstract][Full Text] [Related]
17. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583 [TBL] [Abstract][Full Text] [Related]
18. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors. Hille-Betz U; Vaske B; Bremer M; Soergel P; Kundu S; Klapdor R; Hillemanns P; Henkenberens C Strahlenther Onkol; 2016 Jan; 192(1):8-16. PubMed ID: 26416291 [TBL] [Abstract][Full Text] [Related]
19. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related]
20. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Markiewicz DA; Schultz DJ; Haas JA; Harris EE; Fox KR; Glick JH; Solin LJ Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):661-8. PubMed ID: 8690631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]